Altered hypothalamo-pituitary-adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates.
Wistar rats have been selectively bred for high (HABs) or low (LABs) anxiety-related behavior based on results obtained in the elevated-plus maze. They also display robust behavioral differences in a variety of additional anxiety tests. The present study was undertaken to further characterize physiological substrates that contribute to the expression of this anxious trait. We report changes in brain and peripheral structures involved in the regulation of both the hypothalamo-pituitary-adrenal (HPA) and sympatho-adrenal systems. Following exposure to a mild stressor, HABs displayed a hyper-reactivity of the HPA axis associated with a hypo-reactivity of the sympatho-adrenal system and a lower serotonin turnover in the lateral septum and amygdala. At rest, HABs showed a higher adrenal weight and lower tyrosine hydroxylase and phenylethanolamine-N-methyltransferase mRNAs expression in their adrenals than LABs. In the anterior pituitary, HABs also exhibited increased proopiomelanocortin and decreased vasopressin V1b receptor mRNAs expression, whereas glucocorticoid receptor mRNA levels remained unchanged. These results indicate that the behavioral phenotype of HABs is associated with peripheral and central alterations of endocrine mechanisms involved in stress response regulation. Data are discussed in relation to coping strategies adopted to manage stressful situations. In conclusion, HABs can be considered as an useful model to study the etiology and pathophysiology of stress-related disorders and their neuroendocrine substrates.
Salomé
Nicolas
N
Unité de Neurosciences et de Physiologie Adaptatives, Laboratoire de Stress Périnatal, Université de Lille 1, 59655 Villeneuve d'Ascq, France.
Viltart
Odile
O
Lesage
Jean
J
Landgraf
Rainer
R
Vieau
Didier
D
Laborie
Christine
C
D000311:Adrenal Glands / Q000294:innervation / Q000378:metabolism* / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001007:Anxiety / Q000378:metabolism* / Q000473:pathology; D015306:Biogenic Monoamines / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D008297:Male; D009490:Neurosecretory Systems / Q000378:metabolism; D009929:Organ Size; D010625:Phenylethanolamine N-Methyltransferase / Q000235:genetics / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000378:metabolism* / Q000473:pathology; D010913:Pituitary-Adrenal System / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D020665:Septum of Brain / Q000378:metabolism; D013045:Species Specificity; D013564:Sympathetic Nervous System / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism
D015306:Biogenic Monoamines; D012333:RNA, Messenger; D000324:Adrenocorticotropic Hormone; D014446:Tyrosine 3-Monooxygenase; D010625:Phenylethanolamine N-Methyltransferase; D003345:Corticosterone